IL17A and neoplasm: If the inflammation cannot be resolved and the mucosal barrier is unrepairable, cytokines that help tumor cells to proliferate, such as IL-36, TNF, IL-6 or IL-17, or cytokines that reduce the activity of tumor-eliminating immune cells, such as IFN-γ or TNF, are already at the site of tumor development.